Improvement of Platelet Respiration by Cell-Permeable Succinate in Diabetic Patients Treated with Statins.
Improvement of Platelet Respiration by Cell-Permeable Succinate in Diabetic Patients Treated with Statins.
复制标题
DOI:
10.3390/life11040288
复制
发表时间:
2021-03-28
期刊:
影响因子:
--
通讯作者:
Crețu OM
中科院分区:
文献类型:
--
作者:
Avram VF;Bîna AM;Sima A;Aburel OM;Sturza A;Burlacu O;Timar RZ;Muntean DM;Elmér E;Crețu OM
Diabetes mellitus (DM) is the most severe metabolic disease that reached the level of a global pandemic and is associated with high cardiovascular morbidity. Statins are the first–line lipid–lowering therapy in diabetic patients with or without a history of atherosclerotic disease. Although well tolerated, chronic treatment may result in side effects that lead to treatment interruption. Mitochondrial dysfunction has emerged as a central pathomechanism in DM– and statin–induced side effects. Assessment of mitochondrial respiration in peripheral platelets has been increasingly used as a mirror of organ mitochondrial dysfunction. The present study aimed to assess the: (i) changes in mitochondrial respiration elicited by statins in patients with type 2 DM and (ii) the effects of cell–permeable succinate (NV118) on respiratory parameters in platelets harvested from these patients. No significant changes were found in global mitochondrial respiration of intact platelets isolated from diabetic patients treated with either atorvastatin or rosuvastatin. Similarly, no significant changes in mitochondrial respiration of permeabilized platelets were found between diabetic patients treated with atorvastatin and healthy controls. Acute ex vivo administration of NV118 significantly improved respiration in isolated platelets. These results prompt further research on the role of permeable succinate as a therapeutic alternative for improving mitochondrial function in metabolic pathologies and point to the role of peripheral platelets as a potential biomarker of treatment response.
登录
查看更多内容
DOI:
10.1152/ajpendo.1998.275.2.e197
发表时间:
1998-08-01
影响因子:
5.1
作者:
Harper, ME;Monemdjou, S;Weindruch, R
通讯作者:
Weindruch, R
影响因子:
16.6
作者:
Ehinger JK;Piel S;Ford R;Karlsson M;Sjövall F;Frostner EÅ;Morota S;Taylor RW;Turnbull DM;Cornell C;Moss SJ;Metzsch C;Hansson MJ;Fliri H;Elmér E
通讯作者:
Elmér E
影响因子:
3.2
作者:
Duncan, Andrew J.;Hargreaves, Iain P.;Heales, Simon J. R.
通讯作者:
Heales, Simon J. R.
DOI:
10.5114/aoms.2016.59938
发表时间:
2016-06-01
期刊:
Archives of medical science : AMS
影响因子:
--
作者:
Gluba-Brzozka A;Franczyk B;Toth PP;Rysz J;Banach M
通讯作者:
Banach M
影响因子:
8.2
作者:
Boushel, R.;Gnaiger, E.;Schjerling, P.;Skovbro, M.;Kraunsoe, R.;Dela, F.
通讯作者:
Dela, F.